Literature DB >> 12556548

Reducing cardiovascular risk in type 2 diabetes.

Caren G Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12556548     DOI： 10.1056/NEJMe020172

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Atorvastatin: a review of its use in the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Reducing CVD risk in type 2 DM.

Authors:  Anthony L McCall
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

3.  Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Scott G Canfield; Ana Sepac; Filip Sedlic; Maria Y Muravyeva; Xiaowen Bai; Zeljko J Bosnjak
Journal:  Anesthesiology       Date:  2012-10       Impact factor: 7.892

Review 4.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.

Authors:  Takashi Uzu; Hiroki Yokoyama; Hirofumi Itoh; Daisuke Koya; Atsushi Nakagawa; Makoto Nishizawa; Hiroshi Maegawa; Yukiyo Yokomaku; Shin-Ichi Araki; Atsuko Abiko; Masakazu Haneda
Journal:  Clin Exp Nephrol       Date:  2010-09-09       Impact factor: 2.801

Review 6.  Risk factor management to prevent first stroke.

Authors:  Tatjana Rundek; Ralph L Sacco
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

7.  Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.

Authors:  Charlene C Quinn; Michelle D Shardell; Michael L Terrin; Erik A Barr; Shoshana H Ballew; Ann L Gruber-Baldini
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

8.  Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2003-02-12       Impact factor: 9.951

Review 9.  Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.

Authors:  Matthias Meier; Michael Hummel
Journal:  Vasc Health Risk Manag       Date:  2009-11-02

10.  Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial.

Authors:  Eun-Young Lee; Jae-Seung Yun; Seon-Ah Cha; Sun-Young Lim; Jin-Hee Lee; Yu-Bae Ahn; Kun-Ho Yoon; Seung-Hyun Ko
Journal:  Int J Environ Res Public Health       Date:  2021-05-16       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.